Caffeine potentiation on lethality of L-1210 cells treated with neocarzinostatin. 1976

M Sasada, and H Sawada, and T Nakamura, and H Uchino

The caffeine potentiation on lethality of L-1210 cells treated with Neocarzinostatin was studied. Colony formation of L-1210 cells treated with Neocarzinostatin was significantly decreased by incubation of the cells for 48 hr with 0.5 mM of caffeine which alone did not affect the growth rate and colony-forming ability of the cells. These results indicate that Neocarzinostatin may induce repairable damage in DNA of L-1210 cells.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D009353 Zinostatin An enediyne that alkylates DNA and RNA like MITOMYCIN does, so it is cytotoxic. Neocarzinostatin
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Sasada, and H Sawada, and T Nakamura, and H Uchino
May 1971, Mutation research,
M Sasada, and H Sawada, and T Nakamura, and H Uchino
January 1975, Folia histochemica et cytochemica,
M Sasada, and H Sawada, and T Nakamura, and H Uchino
January 1986, Folia biologica,
M Sasada, and H Sawada, and T Nakamura, and H Uchino
October 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M Sasada, and H Sawada, and T Nakamura, and H Uchino
July 1973, Biochimica et biophysica acta,
M Sasada, and H Sawada, and T Nakamura, and H Uchino
July 1979, Radiation research,
M Sasada, and H Sawada, and T Nakamura, and H Uchino
January 1983, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M Sasada, and H Sawada, and T Nakamura, and H Uchino
May 1979, Cancer research,
M Sasada, and H Sawada, and T Nakamura, and H Uchino
June 1968, Nature,
Copied contents to your clipboard!